Amycretin vs Dulaglutide

Amycretin is an experimental drug that combines two hormone signals (amylin and GLP-1) to help control blood sugar and appetite, but it is not yet approved by the FDA for any use. Dulaglutide, sold under the brand name Trulicity, is an FDA-approved GLP-1 drug that helps treat type 2 diabetes and reduce cardiovascular risks; it is given as a weekly injection.

AI summary of the sources below.